Education
About Us
Working with TipRanks
Follow Us
Grifols SA (GRFS)
:GRFS
Earnings Data
Report Date
Feb 26, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.29Last Year’s EPS
0.11Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlights Grifols' robust financial performance, with significant revenue growth, improved adjusted EBITDA, and strengthened free cash flow. The company has made progress in deleveraging and gaining market share, particularly in the immunoglobulins franchise. However, challenges such as pricing pressures in China and exchange rate headwinds persist, along with a delay in regulatory approval for fibrinogen in the U.S. Despite these challenges, the overall sentiment leans towards positive, given the strong financial and operational metrics.Company Guidance
Strong Revenue Growth
Grifols achieved revenue of EUR 5.5 billion year-to-date, representing a year-over-year increase of 7.7% and 10.5% like-for-like after adjustments, both at constant currency.
Impressive Adjusted EBITDA
Adjusted EBITDA for the third quarter was EUR 482 million, contributing to a year-to-date adjusted EBITDA of EUR 1,358 million, up 11.2% and 17.3% like-for-like, both at constant currency.
Significant Improvement in Free Cash Flow
Year-to-date free cash flow pre-M&A and pre-dividends improved by EUR 257 million year-over-year, reaching EUR 188 million.
Market Share Gains in Immunoglobulins
The immunoglobulins franchise outpaced the market with 18% growth in the quarter and 14% year-to-date, driven by GAMUNEX and XEMBIFY.
Deleveraging Success
Grifols reduced its leverage ratio to 4.2x by the end of Q3, nearly a 1x improvement over the prior year.
GRFS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GRFS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | $9.43 | $9.22 | -2.23% |
Jul 29, 2025 | $9.96 | $10.36 | +4.02% |
May 12, 2025 | $7.00 | $7.63 | +9.00% |
Feb 26, 2025 | $7.28 | $7.83 | +7.55% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Grifols SA (GRFS) report earnings?
Grifols SA (GRFS) is schdueled to report earning on Feb 26, 2026, Before Open (Confirmed).
What is Grifols SA (GRFS) earnings time?
Grifols SA (GRFS) earnings time is at Feb 26, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GRFS EPS forecast?
GRFS EPS forecast for the fiscal quarter 2025 (Q4) is 0.29.